ABEONA THERAPEUTICS INC's ticker is ABEO and the CUSIP is 00289Y107. A total of 48 filers reported holding ABEONA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $12,000 | -14.3% | 65,073 | -0.5% | 0.00% | 0.0% |
Q2 2022 | $14,000 | -33.3% | 65,414 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $21,000 | -4.5% | 65,414 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $22,000 | -84.9% | 65,414 | -50.0% | 0.00% | -66.7% |
Q3 2021 | $146,000 | +43.1% | 130,828 | +100.0% | 0.00% | -25.0% |
Q2 2021 | $102,000 | -17.1% | 65,414 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $123,000 | +19.4% | 65,414 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $103,000 | +53.7% | 65,414 | 0.0% | 0.01% | +66.7% |
Q3 2020 | $67,000 | -64.9% | 65,414 | 0.0% | 0.00% | -70.0% |
Q2 2020 | $191,000 | +39.4% | 65,414 | 0.0% | 0.01% | +11.1% |
Q1 2020 | $137,000 | -36.0% | 65,414 | 0.0% | 0.01% | -18.2% |
Q4 2019 | $214,000 | +44.6% | 65,414 | 0.0% | 0.01% | +22.2% |
Q3 2019 | $148,000 | -52.7% | 65,414 | 0.0% | 0.01% | -50.0% |
Q2 2019 | $313,000 | -34.9% | 65,414 | 0.0% | 0.02% | -37.9% |
Q1 2019 | $481,000 | +3.0% | 65,414 | 0.0% | 0.03% | -9.4% |
Q4 2018 | $467,000 | -44.2% | 65,414 | 0.0% | 0.03% | -33.3% |
Q3 2018 | $837,000 | -20.1% | 65,414 | 0.0% | 0.05% | -26.2% |
Q2 2018 | $1,047,000 | +11.5% | 65,414 | 0.0% | 0.06% | +8.3% |
Q1 2018 | $939,000 | -9.5% | 65,414 | 0.0% | 0.06% | -7.7% |
Q4 2017 | $1,037,000 | -7.0% | 65,414 | 0.0% | 0.06% | -13.3% |
Q3 2017 | $1,115,000 | +166.1% | 65,414 | 0.0% | 0.08% | +158.6% |
Q2 2017 | $419,000 | +28.1% | 65,414 | 0.0% | 0.03% | +31.8% |
Q1 2017 | $327,000 | +3.2% | 65,414 | 0.0% | 0.02% | 0.0% |
Q4 2016 | $317,000 | -19.1% | 65,414 | 0.0% | 0.02% | -24.1% |
Q3 2016 | $392,000 | +154.5% | 65,414 | 0.0% | 0.03% | +141.7% |
Q2 2016 | $154,000 | -7.8% | 65,414 | 0.0% | 0.01% | -14.3% |
Q1 2016 | $167,000 | -24.1% | 65,414 | 0.0% | 0.01% | -22.2% |
Q4 2015 | $220,000 | -17.0% | 65,414 | 0.0% | 0.02% | -21.7% |
Q3 2015 | $265,000 | -19.9% | 65,414 | 0.0% | 0.02% | -14.8% |
Q2 2015 | $331,000 | – | 65,414 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 1,359,767 | $3,209,000 | 1.04% |
DAFNA Capital Management LLC | 181,818 | $429,000 | 0.34% |
Perceptive Advisors | 1,762,881 | $4,159,000 | 0.29% |
NEXTHERA CAPITAL LP | 100,000 | $236,000 | 0.20% |
SPHERA FUNDS MANAGEMENT LTD. | 138,105 | $326,000 | 0.08% |
Soros Fund Management | 1,462,122 | $3,451,000 | 0.07% |
SABBY MANAGEMENT, LLC | 270,000 | $637,000 | 0.03% |
CAMBRIDGE TRUST CO | 65,414 | $154,000 | 0.01% |
PRELUDE CAPITAL MANAGEMENT, LLC | 30,000 | $71,000 | 0.01% |
ROYCE & ASSOCIATES LP | 376,321 | $888,000 | 0.01% |